Search Results 1141-1150 of 8071 for 78%
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
A Study Evaluating the Efficacy and Safety of Botulinum Toxin Type A and Solifenacin in Patients with Overactive Bladder and Urinary Incontinence.
Olaparib and onalespib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of ...
About this study. The primary purpose of this study is to identify women with Primary Hyperoxaluria (PH) who have had pregnancies from a large, ...
The purpose of this study is to employ patient and community engagement to develop recruitment strategies and provide input to a future clinical trial of a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.